Overview

A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to evaluate the safety and effectiveness of memantine Add-On treatment of patients who are currently taking an SNRI or SSRI and who remain anxious and symptomatic despite treatment. Secondary objectives of this study are: •-to evaluate if there is an improvement in disability levels following memantine dosing -to evaluate if there is an improvement in sleep quality following memantine dosing

Phase:

Phase 3

Details

Lead Sponsor:

State University of New York - Upstate Medical University

Treatments:

Memantine
Serotonin Uptake Inhibitors